Société BriaCell Therapeutics Corp. Nasdaq
Actions
BCTX
CA1079301091
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,26 USD | +0,89% | +0,89% | -61,37% |
Métier
Nombre d'employés: 16
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01/02/16 |
Chief Tech/Sci/R&D Officer | 53 | 01/05/21 | |
Chief Tech/Sci/R&D Officer | 62 | 16/02/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10/05/16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31/08/21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07/03/18 |
Director/Board Member | 66 | 18/03/19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Jane Gross
BRD | Director/Board Member | 67 | 01/11/21 |
Chairman | 39 | 04/02/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 15 981 726 | 14 020 125 ( 87,73 %) | 0 | 87,73 % |
Coordonnées société
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+2,97% | 108 Md | |
+10,21% | 105 Md | |
+1,57% | 23,46 Md | |
-12,77% | 21,72 Md | |
-7,05% | 18,64 Md | |
-37,64% | 17,45 Md | |
-6,50% | 17,19 Md | |
+6,00% | 13,99 Md | |
+37,20% | 12,53 Md |
- Bourse
- Actions
- Action BCT
- Action BCTX
- Société BriaCell Therapeutics Corp.